I-Herpes Simplex Virus (HSV) kunye ne-HIV

Ukutshatyalaliswa kwezifo zesifo kunokunyusa umngcipheko wosulelo

Intsholongwane yeHerpes simplex (HSV) yimbangela eqhelekileyo yezifo zesikhumba sesilonda emzimbeni womntu omzimba onokukhubazeka. Usulelo lunokubangela i-HSV uhlobo 1 (HSV-1) okanye uhlobo lwe-HSV 2 (HSV-2), kwaye lubonise njengomlomo we- herpe (ii- zilonda ezibandayo okanye i- blisters ye-fever ) okanye i- herpe yomzimba (ebizwa ngokuba yi- herpes ).

I-HSV inokudluliselwa ngokukhawuleza ngokuqhagamshelana ngqo kunye nesifo esicacileyo okanye umzi womzimba womntu osulelekileyo, nangona isifo singenzeka nangona kungekho zibonakaliso ezibonakalayo.

Izithintelo zokukhusela ngendlela yamakhondom okanye amantombazana angamazinyo anganciphisa umngcipheko wokusasazeka; Nangona kunjalo, usulelo luya kwenzeka kwiindawo zomzimba ezingakhange zikhutshwe ngekhondom.

Namhlanje, i-herpes yomzimba yenye yezona zifo zixhaphakileyo ngokwesini, ngokuqikelelwa ku-775,000 ukusuleleka kwi-US ngamnye ngonyaka. Kule ndawo, i-80% ayinakuqonda ngokupheleleyo ukuba isifo.

I-HSV Infection and Symptoms

I-HSV-1 idla ngokufumaneka ngexesha lobuncinci kwaye idibene ngokuqhelekileyo kunye ne-herpes yomlomo, ngelixa i-HSV-2 isatshatyalaliswa ngokwesondo kwaye iyakuthintela ummandla we-anogenital phakathi kwe-anus kunye nezitho zangasese. Nangona kunjalo, kwiminyaka emashumi amva nje, ukusuleleka komlomo kunye ne-HSV-2 kunye nesifo sobunikazi nge-HSV-1 sele siqhelekile, mhlawumbi ngenxa yemigqaliselo yesondo ngomlomo. Enyanisweni, izifundo ngoku zibonisa ukuba naphi na i-32% ukuya kwi-47% ye- herpes yobulili ibangelwa yi-HSV-1 .

Uninzi lwabantu abane-HSV abanakho iimpawu okanye iimpawu ezinobungozi ezingabonakaliyo.

Xa kubonakala iimpawu, ziqala ngokubonisa ukugqithisa kunye / okanye ukubomvu, zilandelwe izilonda ezinjenge-blister ezixhamla ngokukhawuleza zibe zizilonda ezililayo. Izilonda zisoloko zibuhlungu yaye zihamba kunye nomkhuhlane kunye ne-lymph glands.

I-herpes yomlomo iveza ngokubanzi emlonyeni kwaye ngamanye amaxesha kwimizimba ye-mucosal yezinsini.

I-genital herpes ixhaphake ngokuqhelekileyo kwi-penis, ngaphakathi, emthangeni, emathangeni, kunye ne-anus yabesilisa, ngelixa izilonda zibonakala kakhulu kwi-clitoris, i-pubis, i-vulva, kunye ne-anus yabesifazane.

Bobabini umlomo kunye nomjikelezo we-herpes womzimba phakathi kwezikhathi zesifo esisebenzayo, esinokuhlala kwiintsuku ezimbini ukuya kwiiveki ezintathu, kulandelwa ixesha lokuxolelwa. Emva kokusuleleka kwintsholongwane, iintsholongwane zinamathele kwiiseli zentsholongwane, apho zihlala khona ubomi. I-HSV inokuqalisa kwakhona nayiphi na ixesha (kunye nesiphumo salo naliphi na inani lezinto ezinokubangela ukuba ), nangona ubukhulu bexinzelelo kunye nokuqhaqhaqhazeka kweziqhambuka kudla ukuhlalisa ixesha.

Ukuxilongwa ngokuqhelekileyo kwenziwa ngokuhlolwa kweklinikhi yesigulane, nangona i-herpes yesisu ivame ukuba nzima ukuxilonga njengempawu ezinokuthi zidibanise kwaye zidideke ezinye iimeko (ezifana ne-urethritis okanye isifo sofayo). Iimvavanyo zeLebhansi ngamanye amaxesha zisetyenziselwa ukwenza i-diagnostic ecacileyo, kubandakanywa iimvavanyo zentsholongwane zentsholongwane ye-HSV ezinokuthi zichonge i-HSV-1 okanye i-HSV-2 ibe ngaphezu kwe-98%.

Ikhonkco phakathi kwe-HSV kunye ne-HIV

Abantu abaxhatshazwa ngumzimba, njengokuba banesifo se-HIV, imvama kunye neempawu ze-HSV ziphazamiseka ngamanye amaxesha, zisasazeka emlonyeni okanye kwizitho zangasese zibe zizicubu ezinzulu kwimiphunga okanye engqondweni.

Ngaloo ndlela, i-HSV iye yahlulwa njengesimo "sokuchazwa nguGawulayo" kubantu abanentsholongwane kaGawulayo ukuba bahlala ixesha elide ngaphezu kwenyanga okanye banikele kwimiphunga, i-bronchi okanye isophagus.

Kukho ubungqina obuninzi bokuba ukuhanjiswa kwe-HIV kunxulumene kakhulu neHSV-2. Uphando lwangoku lubonisa ukuba ukusuleleka kwe-HSV-2 esebenzayo, ingaba impawu okanye impawu, ingakwandisa ukukhutshwa kwe-HIV kumathambo e-mucosal kwinkqubo ebizwa ngokuthi "ukutyhala kwegciwane." Ngenxa yesiphulo esinjalo, abantu abanomthamo wentsholongwane kaGawulayo ongenakubonakalayo, ngokwenene, banokuthi bafumane umsebenzi we-viral in secret sections.

Nangona ukusetyenziswa kwonyango lwe-antiretroviral (ikarita) eyaziwa ngokunciphisa iziganeko ze-HSV ezibonisa impawu, akuthethi ukunciphisa i-HIV.

Ngenxa yoko, abantu abane-HIV abane-HSV-2 esebenzayo ukusuleleka ku-kathathu amaxesha amaninzi amathuba okudlulisela i-HIV kumlingani wesini.

Ngokufanayo, abantu abanentsholongwane kaGawulayo abane-HSV-2 esebenzayo ukusuleleka kwingozi yokufumana i-HIV. Oku akukhona nje ngokuba izilonda ezivulekileyo zibonelela ngokulula kwi-HIV, kodwa ngenxa yokuba i-HIV ibophezela ngokubanzi kwi-macrophages efunyenwe kwiinkcazo kwiintsholongwane zentsholongwane. Ngokwenza njalo, i-HIV ingakwazi ukuqhuba ngokuphumelelayo umqobo we-mucosal wesini okanye i-anus ngqo kwigazi.

Unyango kunye nokuthintela

Akukho okwangoku akukho unyango malunga ne-HSV-1 okanye i-HSV-2.

Izidakamizwa zokusetyenziswa kwe-anti-virus zingasetyenziselwa ukuphatha i-HSV, edla ngokufuna amazinga aphezulu kubantu abane-HIV. Amachiza angasetyenziswa ngokugqithiseleyo (xa ususuleleka sulelo okanye ngexesha lokuqhubela phambili) okanye ngokuqhubekayo, unyango oluxhasayo kulabo abanokuqhawuka ngokuphindaphindiweyo.

Ezi zintathu ze-antitivirals ezisetyenziselwa ukuphatha i-HSV yi- Zovirax (acyclovir) , i-Valtrex (i-valacyclovir), ne-Famvir (famciclovir). Ezi zilawulwa kwifom ye-pilice yomlomo, nangona iimeko ezinzima zingaphathwa nge-acyclovir ene-intraveous acyclovir. Uninzi lwemiphumo yecala yeziyobisi ithathwa njengobumnene, inentloko, isifo sohudo, isicupunu, kunye namaqhwa omzimba ziphakathi kwezona ziqhelekileyo.

Ukunyangwa kwe-HSV unyango kunganciphisa umngcipheko wokudluliselwa kwe-HSV ngamashumi ama-50%, ngokukodwa ngokusetyenziswa kwekhondom eqhubekayo. Ngelixa unyango oluthintekayo alubonakalwanga ukunciphisa ingozi ye-HIV, uphando oluthile lubonise ukuba ukusetyenziswa kwansuku zonke komlomo we-acyclovir kudibene nomthwalo we-HIV ophantsi kunye nokubonakala kwezantsi kwezilonda zesisu.

Ukunciphisa umngcipheko wokufumana okanye ukudlulisela i-HIV ukuba unayo i-HSV:

Imithombo:

Amaziko e-US for Control and Prevention (CDC) yeZifo. "I-Genital Herpes - i-CDC Fact Sheet." Atlanta, Georgia; fi kelele ngo-Matshi 26, 2014.

UWald, A. "Izifo zentsapho zeHSV." Izifo ezithathelwana ngesondo. Juni 2006; 82 (3): 189-190.

Peña, K .; Adelson, M .; UMordekayi, E; okqhubekayo. "I-Genital Herpes I-Simplex Virus Type 1 kwiBasetyhini: Ukufumanisa kwiCervicovaginal Specimens kwi-Gynecological Practic e-United States." Umbhalo we-Clinical Microbiology. Ja nuwari 2010; 48 (1): 150-153.

Corey, L .; IWald, A .; Celum, C; okqhubekayo. "Imiphumo yesifo sengqondo se-herpes simplex-2 kwi-HIV-1 yokufumana nokuhanjiswa: ukuhlaziywa kwezifo ezigulayo ezimbini." I-Journal ye-Immune Deficiency Syndromes. Epreli 2004; 35 (5): 435-45.

Grey, R .; Wawer, M .; Brookmeyer, R .; okqhubekayo. "Ubungenako bokutshatyalaliswa kwe-HIV-1 ngomsebenzi ngamnye womtshato kwisigidimi esisodwa, i-HIV-1-couples-discordant couples in Rakai, Uganda." Lancet. Epreli 2001; 357 (9263): 1149-1153.

Corey, L .; IWald, A .; Patel, R .; al. "Ngenye imini i-valacyclovir ukunciphisa umngcipheko wokusasazwa kweedpepes zomzimba." I-New England Journal of Medicine. Ja nuwari 2004; 350 (1): 11-20.

Celum, C; IWald, A .; Lingappa, J .; okqhubekayo. "I-Acyclovir kunye nokudluliselwa kwe-HIV-1 kubantu abasulelekileyo abane-HIV-1 ne-HSV-2." I-New England Journal of Medicine. Fe bruwari 4, 2010; 362 (5): 427-39.